Guest lecture at Vrije Universiteit Amsterdam on global health and antimicrobial resistance

Moska Hellamand (left) and Martijn van Gerven (right) are both researchers at the Foundation. 

AMR is rising faster than expected. In 2019 alone, 1.27 million people died of drug-resistant infections, most of them in low-and middle income countries (LMICs). 

Moska and Martijn are both researchers in the Access to Medicine Foundation's Antimicrobial Resistance Programme, which takes an in-depth look at how the pharmaceutical industry is responding to the growing challenge of drug-resistant infections. 

They have been invited to share their insights, particularly around AMR, by giving a lecture at VU Amsterdam's Faculty of Medicine. The lecture forms part of a one-month course on Global Health, focusing on LMICs with a high burden of diseases. This course is is taken by medical students who take the module on 'Global Health, Indonesia', which is aimed at understanding healthcare issues from a cultural perspective. 

Some of the key topics Moska and Martijn will be covering include:

• The goal and work of the Access to Medicine Foundation.

• Antimicrobial resistance (AMR), particularly within the Indonesian context.

• Key findings of the Foundation's 2021 Antimicrobial Resistance Benchmark.

• Insights from the Foundation's recent paper on how the pharmaceutical industry can take action to help curb the fast-rising AMR global health crisis by expanding access to antibiotics and antifungals in LMICs.